These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34421881)

  • 1. The
    Zhou H; Gebhardt MJ; Czyz DM; Yao Y; Shuman HA
    Front Microbiol; 2021; 12():723949. PubMed ID: 34421881
    [No Abstract]   [Full Text] [Related]  

  • 2. GigA and GigB are Master Regulators of Antibiotic Resistance, Stress Responses, and Virulence in Acinetobacter baumannii.
    Gebhardt MJ; Shuman HA
    J Bacteriol; 2017 May; 199(10):. PubMed ID: 28264991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint Transcriptional Control of Virulence and Resistance to Antibiotic and Environmental Stress in Acinetobacter baumannii.
    Gebhardt MJ; Gallagher LA; Jacobson RK; Usacheva EA; Peterson LR; Zurawski DV; Shuman HA
    mBio; 2015 Nov; 6(6):e01660-15. PubMed ID: 26556274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative proteomics analyses of Acinetobacter baumannii strains ATCC 17978 and AB5075 reveal the differential role of type II secretion system secretomes in lung colonization and ciprofloxacin resistance.
    Elhosseiny NM; Elhezawy NB; Attia AS
    Microb Pathog; 2019 Mar; 128():20-27. PubMed ID: 30578836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An
    Tipton KA; Rather PN
    J Bacteriol; 2017 Feb; 199(3):. PubMed ID: 27872182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of tetR type regulator adeN by mobile genetic element confers elevated virulence in Acinetobacter baumannii.
    Saranathan R; Pagal S; Sawant AR; Tomar A; Madhangi M; Sah S; Satti A; Arunkumar KP; Prashanth K
    Virulence; 2017 Oct; 8(7):1316-1334. PubMed ID: 28436748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CsrA Coordinates Compatible Solute Synthesis in Acinetobacter baumannii and Facilitates Growth in Human Urine.
    Hubloher JJ; Schabacker K; Müller V; Averhoff B
    Microbiol Spectr; 2021 Dec; 9(3):e0129621. PubMed ID: 34730379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miltefosine Reduces the Cytolytic Activity and Virulence of
    Fiester SE; Arivett BA; Beckett AC; Wagner BR; Ohneck EJ; Schmidt RE; Grier JT; Actis LA
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The
    Weidensdorfer M; Ishikawa M; Hori K; Linke D; Djahanschiri B; Iruegas R; Ebersberger I; Riedel-Christ S; Enders G; Leukert L; Kraiczy P; Rothweiler F; Cinatl J; Berger J; Hipp K; Kempf VAJ; Göttig S
    Virulence; 2019 Dec; 10(1):68-81. PubMed ID: 31874074
    [No Abstract]   [Full Text] [Related]  

  • 10. Two
    Grier JT; Arivett BA; Ramírez MS; Chosed RJ; Bigner JA; Ohneck EJ; Metz ML; Wood CR; Arce S; Tartaro A; Relich RF; Actis LA; Fiester SE
    Front Cell Infect Microbiol; 2021; 11():635673. PubMed ID: 33912474
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel Genes Required for Surface-Associated Motility in Acinetobacter baumannii.
    Blaschke U; Skiebe E; Wilharm G
    Curr Microbiol; 2021 Apr; 78(4):1509-1528. PubMed ID: 33666749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimisation of the Caenorhabditis elegans model for studying the pathogenesis of opportunistic Acinetobacter baumannii.
    Vallejo JA; Beceiro A; Rumbo-Feal S; Rodríguez-Palero MJ; Russo TA; Bou G
    Int J Antimicrob Agents; 2015 Jul; ():. PubMed ID: 26213382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075.
    Anderson SE; Sherman EX; Weiss DS; Rather PN
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30111627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance.
    Wand ME; Bock LJ; Bonney LC; Sutton JM
    J Antimicrob Chemother; 2015 Aug; 70(8):2209-16. PubMed ID: 25904728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Shuttle Vectors for Real-Time Gene Expression Analysis in Multidrug-Resistant Acinetobacter Species:
    Lucidi M; Visaggio D; Prencipe E; Imperi F; Rampioni G; Cincotti G; Leoni L; Visca P
    Appl Environ Microbiol; 2019 Sep; 85(18):. PubMed ID: 31324623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase-Variable Control of Multiple Phenotypes in Acinetobacter baumannii Strain AB5075.
    Tipton KA; Dimitrova D; Rather PN
    J Bacteriol; 2015 Aug; 197(15):2593-9. PubMed ID: 26013481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete genome sequence and genome-scale metabolic modelling of Acinetobacter baumannii type strain ATCC 19606.
    Zhu Y; Lu J; Zhao J; Zhang X; Yu HH; Velkov T; Li J
    Int J Med Microbiol; 2020 Apr; 310(3):151412. PubMed ID: 32081464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of RelA in Acinetobacter baumannii.
    Pérez-Varela M; Tierney ARP; Kim JS; Vázquez-Torres A; Rather P
    J Bacteriol; 2020 May; 202(12):. PubMed ID: 32229531
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Tao Y; Duma L; Rossez Y
    Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zur-regulated lipoprotein A contributes to the fitness of Acinetobacter baumannii.
    Lee EK; Choi CH; Oh MH
    J Microbiol; 2020 Jan; 58(1):67-77. PubMed ID: 31898255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.